Regulatory T cells (T~regs~) are dominant negative regulators of many facets of the immune system, controlling immune responses and enforcing peripheral tolerance to self, symbiotic commensals and fetal antigens ^[@R1]^. In addition, some T~regs~ reside in non-lymphoid tissues, where they help control tissue homeostasis and sterile inflammation ^[@R2]^.

T~regs~ constitute a diverse constellation of cells ^[@R1],[@R3],[@R4]^. Their origins are diverse ^[@R5]^: many T~regs~ differentiate in the thymus, but others arise in the periphery from naive CD4^+^ T cells upon suboptimal exposure to antigen, in particular microbial. Their organismal locations vary: they reside in the T-cell zones of lymphoid organs, but also in B cell areas where they control antibody maturation and production (Tfr, T follicular regulators), in autoimmune or tumoral lesions, at body/microbiota interfaces. Their effector pathways are heterogeneous: T~regs~ utilize cell-surface inhibitors like CTLA4, inhibitory cytokines like IL-10, IL-35 or TGF-β, cytokine capture via the IL-2 receptor, purine-mediated suppression, or direct cytoxicity ^[@R6]^. These facets correspond to diverse T~reg~ subphenotypes ^[@R1],[@R3],[@R4]^. Particular T~reg~ subtypes have been recognized based on chemokine receptor expression like CXCR3 (CXCR3^+^ T~regs~ are particularly adept at suppressing Th1 responses ^[@R7]--[@R9]^) or CXCR5 (in T follicular regulatory cells (Tfr) ^[@R10],[@R11]^), or activation markers (in "eT~regs~" or "aT~regs~") ^[@R12]--[@R15]^. These more activated types of T~regs~ are particularly represented among extra-lymphoid T~regs~ in inflammatory sites ^[@R2]^.

T~regs~ and conventional CD4^+^FoxP3^−^ T cells (T~convs~) have opposite immune functions but their molecular distinction can be complicated. Stable expression of FoxP3 is semantically eponymous for T~regs~, and FoxP3 controls a substantial fraction of the characteristic transcriptional signature of T~reg~ cells ^[@R16],[@R17]^. However, it is not sufficient, and several other factors, not specific to T~regs~ but also present in T~convs~, are required by T~regs~ ^[@R5]^. Further blurring the T~reg~/T~conv~ distinction, FoxP3 itself can be expressed transiently upon activation in human ^[@R18]^ and mouse ^[@R19]^ T~convs~. Conversely, while the T~reg~ phenotype is generally stable, T~regs~ can lose FoxP3 expression under stress, like IL-2 deprivation ^[@R20]--[@R22]^. Finally, T~regs~ can differentiate directly from T~convs~ in tolerogenic contexts, in order to promote peaceful coexistence with commensal microbiota ^[@R23],[@R24]^ or fetal antigens ^[@R25]^.

The T cell receptor (TCR) plays a central role in T~reg~ life story ^[@R26]^. It is necessary for T~reg~ differentiation, and the signals it delivers upon MHC-peptide recognition, conditioned by costimulatory and other modulators, rescues precursor cells from clonal deletion. Continued TCR presence and engagement by MHC molecules is required for suppressive activity and differentiation to an activated phenotype ^[@R27],[@R28]^. The T~reg~ TCR repertoire is skewed towards recognition of self-antigens, but is as broad as that of T~convs~ ^[@R26],[@R29]^.

Understanding T~reg~ molecular diversity and definition, in relation to T~conv~ cells, is thus complex and confounded by the different states that both populations can adopt in response to various stimuli. Single-cell transcriptome analysis offers the potential to illuminate these questions, in an unbiased manner that does not rely on assumptions of cell-type identities ^[@R30]--[@R37]^. Although scRNAseq remains challenging due to the limiting sensitivity of detection, and the large dimensionality of the data, the approach has been transformative ^[@R38]^, e.g. in identifying novel cell-types ^[@R39]^, and in dissecting transcriptional differences that were previously masked by the "averaging" inherent to profiling RNA from pooled cells (e.g. ^[@R40],[@R41]^).

Here, we apply scRNAseq to profile thousands of single T~reg~ and T~conv~ cells, in mice and humans, to reveal the diversity of transcriptional phenotypes that can be adopted by T~regs~. We concentrate on two driving questions: how T~regs~ and T~convs~ are related; and how TCR-mediated signals affect T~reg~ activation. For focus, we limit the present analysis to T~reg~ and T~conv~ cells from lymphoid organs. The results reveal an unexpected degree of overlap between T~regs~ and T~convs~ and provide a framework integrating many prior observations on effector T~reg~ states.

RESULTS {#S1}
=======

CD4^+^ T~reg~ and T~conv~ scRNAseq datasets {#S2}
-------------------------------------------

In order to maximize the power to find small (sub)populations of cells and significant gene correlations, we performed single-cell transcriptomics on thousands of single cells using InDrop, encapsulating single T~reg~ and T~conv~ cells in microfluidic droplets ^[@R33],[@R42]^. We sorted CD4^+^TCRβ^+^ GFP^+^ T~reg~ and GFP^−^ T~conv~ cells from *Foxp3*^*gfp*^ mice ([Fig. 1a](#F1){ref-type="fig"}) and encapsulated them separately at high efficiency (70--80%) prior to scRNAseq library construction ^[@R42]^. Over the course of this study, we analyzed 4,237 splenic T~regs~ (in 3 independent cell cohorts) and 1,093 splenic T~convs~ (1 cohort matching T~reg~ \#1). In order to minimize batch effect and assess robustness of the results, each T~reg~ cohort was analyzed independently, and the reproducibility of the cell or gene clusters confirmed in the replicates. We extended these data by scRNAseq of total splenic CD4^+^ T cells (n = 2508, containing T~regs~ and T~convs~) using a different microfluidic platform (10X Genomics) and library protocol, and by a plate-based approach where individually sorted T~regs~ were analyzed by CelSeq ^[@R32]^ (n = 200) ([Supplementary Table 1](#SD3){ref-type="supplementary-material"}).

On average, 1,751 unique mRNA molecules representing 787 genes were detected per single cell in the primary InDrop datasets, altogether surveying 16,720 genes ([Fig. 1b](#F1){ref-type="fig"}). All batches had similar coverage ([Fig. 1b](#F1){ref-type="fig"}) and we observed good concordance between them for both the mean ([Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}) and the variation in gene expression ([Supplementary Fig. 1b](#SD1){ref-type="supplementary-material"}). One of the advantages of single-cell over population profiling is that rare contaminating cells from the sort can be identified, and we used for identification a naive Bayes algorithm that compares each single-cell transcriptome with each of the 249 immune-cell states profiled by the Immgen Consortium (here, 3.5% of the cells were identified as contaminants - mostly B and myeloid cells - and culled; [Supplementary Fig. 1c](#SD1){ref-type="supplementary-material"}). As a reality check, *Foxp3* and *Il2ra*, two important T~reg~ markers, were expressed throughout the different T~regs~, and rarely in T~conv~, as expected ([Fig. 1c](#F1){ref-type="fig"}). More generally, the changes in gene expression between T~reg~ and T~conv~ were conserved compared with a standard population RNAseq and substantially overlapped published T~reg~ and T~conv~ specific signatures ^[@R17]^ ([Supplementary Fig. 1d](#SD1){ref-type="supplementary-material"}).

Transcriptional relationship between CD4^+^ T~reg~ and T~conv~ cells {#S3}
--------------------------------------------------------------------

As discussed above, T~reg~ and T~conv~ cells are ontogenetically related, and can derive from one another in some circumstances. Many profiling analyses at the population level have shown that a clear and reproducible gene expression signature distinguishes the two cell types, with *Foxp3* the most extreme example of a T~reg~-specific gene. The averaging generated by population-level profiling can mask complexities in this relationship, so we explored our scRNAseq data specifically in this light. We focus here on splenic populations of unperturbed mice, where T~reg~ and T~conv~ populations are generally agreed to be stable, as opposed to locations of cell stress, where instability has been observed ^[@R43]^.

We first used t-distributed stochastic neighborhood embedding (tSNE) ^[@R44]^ for dimensionality reduction to relate independently sorted splenic T~reg~ and T~conv~ cells (sorted independently according to phenotype in the *Foxp3-gfp* mice; [Fig. 2a,b](#F2){ref-type="fig"}). Although T~reg~ and T~conv~ cells generally partitioned into two main areas (D and E in [Fig. 2a](#F2){ref-type="fig"}), they were also somewhat imbricated: (i) some T~reg~ cells were found in the main T~conv~ area (hereafter referred to as "furtive" T~regs~) and vice versa (best seen in [Fig. 2b](#F2){ref-type="fig"}, top row); and (ii) there were groups of cells in which T~regs~ and T~convs~ comingled apart from the bulk T~reg~ and T~conv~ pools (areas A, B and C, demarcated in [Fig. 2a](#F2){ref-type="fig"} by bootstrap-optimized partition clustering). Differences in sequencing coverage ^[@R45]^ were unlikely to explain this clustering as the distribution of detected genes and number of reads were similar in the different areas ([Supplementary Fig. 2a,b](#SD1){ref-type="supplementary-material"}). In addition, similar patterns were observed on additional T~reg~ and T~conv~ datasets generated with two other scRNAseq platforms: the 10x Genomics platform, or 96-well-sorted cells profiled by CEL-Seq ([Supplementary Fig. 2 c-e](#SD1){ref-type="supplementary-material"}).

Furtive T~regs~ represented 26% of splenic T~regs~ in these experiments. *Foxp3* transcripts were detectable in many of them ([Fig. 2b](#F2){ref-type="fig"}, lower row), at levels comparable with those of other T~regs~ ([Fig. 2c](#F2){ref-type="fig"}). Cytometric sorting of T~regs~ into plates for scRNAseq allowed us to relate protein levels to the transcriptome in single-cells, which showed that furtive T~regs~ expressed FoxP3 protein at the same level as other T~regs~ ([Supplementary Fig. 2e,f](#SD1){ref-type="supplementary-material"}). Furtive T~regs~ were therefore unlikely to result from mis-expression of the reporter or from contaminating cells in the initial sort (plus, at 26% of the splenic T~regs~ profiled, furtive T~regs~ represented far more than the 3.5% contamination rate in the dataset). Canonical T~reg~ signature genes were also over-expressed in these cells compared with surrounding T~conv~ cells ([Fig. 2d](#F2){ref-type="fig"}). However, some of the T~reg~ signature transcripts were shifted in those cells relative to bulk T~regs~ ([Fig. 2e](#F2){ref-type="fig"}), including *Il2ra* and *Ikzf2* (encodes Helios), an important TF in T~reg~ cells ^[@R46],[@R47]^. Furtive T~regs~ also over-expressed *Rel*, *Cd177* and a few transcripts genes normally associated with T~convs~ (*Itgb4*) ([Fig. 2f](#F2){ref-type="fig"}).

In addition to these T~conv~-like T~regs~, we also observed some T~regs~ and T~convs~ in discrete clusters at the interface (areas A-B-C in [Fig. 2a](#F2){ref-type="fig"}), which were separated from the major T~reg~ and T~conv~ populations and clustered together instead. In area A ([Fig. 2g,h](#F2){ref-type="fig"}), both T~regs~ and T~convs~ over-expressed a set of genes associated with residence in B cell follicles \[i.e. T follicular helper (Tfh) and Tfr cells\], including the characteristic *Cxcr5* and *Icos* transcripts ^[@R48]^. In area B ([Fig. 2i,j](#F2){ref-type="fig"}), T~conv~ and T~reg~ cells both upregulated a set of genes that belong to the early response to TCR engagement in both cells (*Nr4a1, Egr1, Egr2, Myc, Dusp2*) ^[@R49]^, suggesting that TCR signals may drive similar programs in both T~regs~ and T~convs~.

While T~reg~ and T~conv~ cells thus converge to similar subphenotypes defined by the integration of all transcripts through the tSNE algorithm, is there nevertheless an overarching set of transcripts that generally demarcates T~reg~ and T~conv~ identities, independently of subphenotype variation? We systematically compared T~regs~ with their closest T~convs~ (correlation distances) ([Supplementary Fig. 3a](#SD1){ref-type="supplementary-material"}) and identified a small geneset (*Il2ra, Il2rb, Ikzf2, Ctla4, Capg*, *Tnfrsf4*, *Tnfrsf18, Izumo1r*, *Chchd10*, *Gpr83*, and ex officio *Foxp3*) that is overexpressed by all T~regs~ irrespective of their location on the tSNE plot ([Fig. 2k](#F2){ref-type="fig"}). The lack of expression of these genes in T~conv~ cells falling in areas A, B or C indicates that these are true T~conv~ cells, not activated cells transiently expressing FoxP3. These genes are all direct targets of FoxP3: they all contain enhancer elements that bind FoxP3 in chromatin immunoprecipitation experiments ^[@R50],[@R51]^ ([Supplementary Fig. 3b](#SD1){ref-type="supplementary-material"}) and are up regulated upon ectopic FoxP3 expression in T~convs~.

Thus, these data show that while most T~regs~ are generally distinct from T~convs~, and a small core of T~reg~-identifying transcripts can be defined, specific subsets of the two cell types do have considerable overlap.

T~reg~ signature: core transcripts and heterogeneity of expression {#S4}
------------------------------------------------------------------

Switching the analysis to the gene axis, we revisited at the single-cell level the classic T~reg~ signature identified by population transcriptomics ^[@R17],[@R52]^. Collapsing the present single-cell data recapitulated the signature observed in previous microarray or population RNAseq datasets, confirming congruence between the techniques ([Fig. 3a](#F3){ref-type="fig"})

The natural cell-cell variability in gene expression revealed in scRNAseq can be valuable to identify modules of coregulated genes ^[@R33],[@R53],[@R54]^. We thus searched for gene correlations in our data and asked whether the T~reg~ signature behaves as a collection of discrete modules, as suggested by our earlier analyses ^[@R17]^. Within the entire dataset that includes both splenic T~regs~ and T~convs~, there was, as expected, a clear partitioning of T~reg~-up vs T~reg~-down signature transcripts ([Fig. 3b](#F3){ref-type="fig"}), and a generally positive but weak correlation between T~reg~-up transcripts, except for a small cluster of highly correlated genes ([Fig. 3b](#F3){ref-type="fig"}). This cluster encompassed the same core set of T~reg~-specific transcripts (*Il2ra*, *Ctla4*, *Foxp3*, etc) identified in [Fig. 2](#F2){ref-type="fig"} as shared by all T~reg~ cells, independent of other variations. This result confirms that only this small core of over-expressed genes identifies T~regs~, which variably express other genesets as a function of their location or functional subphenotypes, some of which can be shared with T~conv~ counterparts.

As expected, this tightly coregulated core set vanished when we tested for correlations within T~regs~ *only*, aiming to identify co-regulated components independently of their co-variation relative to T~conv~ ([Fig. 3c](#F3){ref-type="fig"}). Little correlation was seen at all, and only three clusters were observed: a small but relatively tight one that included the TNFR family members *Tnfrsf4* and *Tnfrsf18* (encode OX40 and GITR, respectively), another that grouped *Foxp3* and *Il2ra*, and a more loosely coordinated cluster that included several other molecules that mediate T~reg~ function (*Ebi3, Gzmb, Ctla4*). Overall, this paucity of correlation of T~reg~ signature transcripts within T~regs~ indicates that the different subphenotypes result from a diversity of regulatory influences, rather than a few dominant programs.

In conclusion, the T~reg~ signature identified at the population level can be deconvoluted into a tight core of coregulated genes, likely tightly controlled by FoxP3, and otherwise heterogeneous genesets diversely expressed by individual T~regs~.

Splenic T~reg~ heterogeneity revolves around several different poles {#S5}
--------------------------------------------------------------------

In the analyses presented above, we parsed primarily T~reg~ heterogeneity in relation to T~conv~ cells and to the classic T~reg~ signature. Yet other transcriptional features are likely to be important in defining the functional identity of a given T~reg~ cell, features that are not necessarily T~reg~-specific. We thus evaluated the distribution of all transcripts among splenic T~reg~ cells. We centered further analyses on the 100 transcripts with the most variability among T~regs~, above that expected from Poisson sampling statistics ([Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}), and thus the most informative ^[@R33]^ (these most variable genes were the same in the 3 batches of splenic T~regs~) ([Supplementary Table 2](#SD4){ref-type="supplementary-material"}). Unsupervised partition clustering, using a bootstrap approach to optimize the number of clusters and assess their stability ^[@R55]^ ([Supplementary Fig. 4b,c](#SD1){ref-type="supplementary-material"}), grouped the splenic T~regs~ into 6 clusters ([Fig. 4a](#F4){ref-type="fig"} on a subset of transcripts that most characterize the different groups) ([Supplementary Table 3](#SD5){ref-type="supplementary-material"}-[4](#SD6){ref-type="supplementary-material"}). These clusters should probably be thought of as discrete states in a continuum, rather than as strictly independent entities, as seen below. Importantly, the analysis was performed on one cohort of T~regs~ and these distinctions were reproduced in independent datasets of splenic T~reg~ cells ([Supplementary Fig. 4d](#SD1){ref-type="supplementary-material"}), even though the relative proportions of cells in each cluster varied somewhat.

Three main poles could be observed within this partitioning. First, there was a general gradient separating resting and activated T~regs~, as judged by the frequency of transcripts typical of resting T~regs~, *Sell* (encodes CD62L) and *Ccr7*. T~regs~ in clusters 4--6 seemed to be in a resting state, while those in cluster 1--3 cells were in an activated state ([Fig. 4a](#F4){ref-type="fig"}, [Supplementary Fig. 4d](#SD1){ref-type="supplementary-material"}). Second, beyond this separation, cells in cluster 1--3 seemed to adopt two different poles of activated phenotypes. Cells in cluster 3 predominantly expressed a set of transcripts typical of early cell activation (*Nr4a1, Egr1, Egr2, Myc,* also *Dusp2)*, and thus evoke TCR-mediated activation while cells in clusters 1--2 were characterized by a more diverse set of transcripts (*Ccr2, Itgb1, S100a4, S100a6, Icos or Cxcr3)*.

To integrate these data with the body of existing observations on T~reg~ heterogeneity ^[@R4],[@R7],[@R10]--[@R14]^, we probed a large set of signatures that distinguish T~reg~ cells, retrieved from databases or curated in house ([Figs. 4b](#F4){ref-type="fig"}, [Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). The first set distinguish activated and resting T~regs~, and effectively confirmed that clusters 5 and 6 correspond to the most naïve T~regs~, with signatures of a/eT~regs~ defined by high *Prdm1* (encodes BLIMP1) ^[@R56]^, or resulting from homeostatically-driven expansion ^[@R27],[@R57]^. For the *Ep300* (the gene encoding p300) knockout ^[@R58]^, the bias towards activated T~regs~ is consistent with the decreased proportion of activated CD62L^lo^ T~regs~ in these mice. Interestingly, the transcriptional signatures of T~regs~ deficient in several transcriptional cofactors that support T~reg~ differentiation (*Foxo1*, *Bach2*, *Gata3*) ^[@R59],[@R60]^ were under-represented in cells from the activated clusters, congruent with the distribution of *Bach2* expression predominant in resting clusters ([Fig. 4a](#F4){ref-type="fig"}). The third set of signatures identified TCR-delivered signals, defined by direct engagement ^[@R49]^ or by acute gene ablation *in vivo* ^[@R27]^. These signatures clearly tagged cells of cluster 3 as those with the strongest response to TCR signals, consistent with their expression of early response genes. The *Bcl6*-dependent Tfr signature ^[@R11]^ was most clearly enriched in cluster 1, as was a generic signature that distinguishes T~reg~ cells that localize to a variety of tissues and which we already knew to include a substantial component of cell activation. This juxtaposition would suggest that Tfr, which reside in the B cell areas of spleen and lymph nodes, are nonetheless very similar to cells that reside in non-lymphoid tissues and sites of sterile inflammation.

We projected the likelihood for each single cell to belong to any of these main states, based on the expression of the defining genes of [Fig. 4a](#F4){ref-type="fig"} (circular *a posteriori* projections (CAP) plots) ^[@R40]^ ([Fig. 4c](#F4){ref-type="fig"}). Most splenic T~regs~ projected cleanly in one of the main clusters, but with the best definition for activated clusters 1--3, as expected from the gene distinctions of [Figs. 4a](#F4){ref-type="fig"} and [S4d](#SD1){ref-type="supplementary-material"}. Only cluster 4 remained less sharply defined, appearing almost like a transitional group between the resting clusters 5--6 and the TCR-responsive cluster 3. These assignments were again robust and applied effectively to independently derived T~reg~ scRNAseq datasets ([Supplementary Fig. 4e](#SD1){ref-type="supplementary-material"}). We also mapped these clusters back onto the T~reg~/T~conv~ tSNE plot from [Fig. 2](#F2){ref-type="fig"} ([Fig. 4d](#F4){ref-type="fig"}). The resting clusters mapped to the core T~reg~ area, but also included many furtive T~regs~. On the other hand, the activated clusters mapped to the more peripheral regions of overlap with T~convs~ (areas A-C), indicating that T~reg~ activation leads to some convergence with T~convs~.

Since this scRNAseq analysis identified a main resting-\>activated axis as well as clear distinctions between phenotypes of activated T~regs~, it was important to validate independently these observations. We appliedstatistical methods to correct for the low sensitivity of the scRNAseq by calculating the technical dropout probability ^[@R53],[@R61],[@R62]^ ([Fig. 4e](#F4){ref-type="fig"}). Using corrected counts, the scRNAseq data predicted CXCR3 to be predominantly displayed by CD62L^lo^ activated T cells, and that CXCR3 and NR4A1 would be largely mutually exclusive. These predictions were confirmed, with expression of CXCR3 on CD62l^lo^ T~regs~, and the highest levels of CXCR3 on NR4A1^−^ T~regs~ ([Fig. 4e](#F4){ref-type="fig"}). We do note a higher proportion of NR4A1^+^CXCR3^lo^ cells than predicted from the scRNAseq data, perhaps owing to stability of the CXCR3 protein.

We then interrogated these data to determine the frequency and distribution of expression of T~reg~ effector molecules ^[@R6]^ ([Fig. 4f](#F4){ref-type="fig"}). We estimated their frequency of expression after dropout correction as in [Fig. 4e](#F4){ref-type="fig"}, which were consistent with frequencies observed by intracellular flow cytometry analysis of splenic T~regs~ (not shown). Effector molecule expression was not mutually exclusive and we identified coexpressed effector molecules ([Fig. 4f](#F4){ref-type="fig"}). As expected from the above, *Il2ra* and *Ctla4* were by far the most frequent inhibitory molecules. In contrast, there was partial and reciprocally biased expression of *Lrrc32* (encodes GARP, which presents processed TGF-β) and *Tgfb1* on the one hand vs *Gzmb* and *Ebi3*. Finally, *Il10* and *Areg* were preferentially represented in activated clusters but quite rare, consistent with their being deployed preferentially in tissue T~regs~ or at inflammatory sites. Thus, splenic Tregs adopt a continuum of states gravitating around one resting and two activated states with distinct phenotypic and effector functions.

Role of TCR signaling in influencing T~reg~ states {#S6}
--------------------------------------------------

The variable induction of the *Nr4a1* gene module among activated T~regs~ suggested differences in how T~regs~ integrate TCR-derived signals. Signals from the TCR impact at multiple levels of T~reg~ differentiation, activation and suppressive function, so we sought to further explore the role of TCR signaling intensity in shaping T~reg~ states. NR4A1 is a transcription factor whose expression is induced rapidly upon T cell activation, proportionally to TCR signaling intensity ^[@R49],[@R63]^. We took advantage of the *Nr4a1-gfp* reporter mouse, in which the level of GFP displayed by each cell reflects the intensity of TCR-delivered signal ^[@R64]^, and performed scRNAseq on T~regs~ sorted from 3 different zones of GFP expression ([Fig. 5a](#F5){ref-type="fig"}). As expected, the frequency and levels of *Nr4a1* conformed to the origin of the T~regs~ ([Fig. 5a](#F5){ref-type="fig"}). T~regs~ from different Nr4a1 expression bins formed a trajectory from low to high expression ([Fig. 5b](#F5){ref-type="fig"}), reproducing the main axis of T~reg~ heterogeneity observed in [Fig. 4](#F4){ref-type="fig"}.

The data (1,265 to 1,567 cells per bin) were processed and analyzed in the probabilistic framework described for [Fig. 4](#F4){ref-type="fig"}, assigning each cell according to its probability of belonging to clusters 1--6 ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). Two main observations stemmed from this analysis. First, and perhaps surprisingly since one might have expected that high TCR signals would promote an activated state, the proportion of cells falling in the resting pool (i.e. mapping to clusters 5 and 6) was essentially identical for all three bins of GFP expression ([Fig. 5c](#F5){ref-type="fig"}). These results were confirmed by flow cytometry on other mice from this line, which showed an equivalent distribution of CD62L across windows of GFP expression ([Fig. 5c](#F5){ref-type="fig"}). These data are consistent with prior observations that also found no relationship between Nr4a1-GFP activity and eT~reg~ status ^[@R14]^.

On the other hand, and mirroring the biased representation of *Nr4a1* transcripts among activated T~reg~ clusters ([Fig. 4](#F4){ref-type="fig"}), the distribution of activated T~regs~ varied markedly with Nr4a1-GFP intensity. The proportion of cells in cluster 3 increased with GFP, while the proportion of cells in clusters 1 and 2 cells decreased ([Figs. 5d](#F5){ref-type="fig"}, [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). These results were consistent with the distribution of *Nr4a1* transcripts, highest in T~regs~ of cluster 3 in normal mice. In addition, and also consistent with the negatively correlated expression of *Nr4a1* and *Cxcr3* ([Fig. 4](#F4){ref-type="fig"}), we found an under-representation of *Cxcr3*-containing T~regs~ in the GFP-medium and -high pools ([Fig. 5e](#F5){ref-type="fig"}).

Thus, in physiological settings and in the absence of inflammatory challenge, the level of TCR signals does not influence the proportion of activated T~regs~, but markedly skews their phenotypic choices.

Role of TCR specificity in influencing T~reg~ phenotypes {#S7}
--------------------------------------------------------

We then used another approach to investigate the relationship between TCR signals and T~reg~ subphenotypes. If they were connected, one would predict that T~reg~ cells expressing an identical TCR clonotype (same V composition and rearranged CDR3 sequence) would share a transcriptional subphenotype. We adapted the InDrop protocol to obtain both the transcriptome and the TCRαβ variable region sequences from the same single cells (detailed in Methods). We sequenced the TCRs of *Foxp3-gfp*^*+*^ T~reg~ cells from the spleen and colon, the latter because microbiota-driven differentiation and/or expansion of particular clones leads to a higher frequency of repeated clonotypes ^[@R23],[@R24]^. Of the 32 and 138 T~regs~ from spleen and colon for which both TCRα and β.chains could be determined unambiguously, none was repeated in splenic T~regs~, as expected since the repertoire of splenic T~reg~ is very diverse. But 7 clonotypes (defined by identical TCRα and TCRβ nucleotide sequences) were found in two or more of the colonic T~reg~ cells. With two exceptions, these clonotype pairs belonged to cells that mapped close to each other on the tSNE plot ([Fig. 6a](#F6){ref-type="fig"}). In order to evaluate the significance of this apparent proximity, we calculated pairwise cell distances (as Pearson correlation) between the transcriptome of these shared-clonotype cells or between randomly sampled pairs of T~regs~. Indeed, transcriptomes of T~regs~ that shared their TCRs were more closely correlated than by chance (p \< 10^−4^), confirming the significance of the observation ([Fig. 6b](#F6){ref-type="fig"}). Thus, T~reg~ cells that display the same TCR clonotype tend to share transcriptional identity, in keeping with the conclusion that signals from the TCR can mold the subphenotype adopted by activated T~regs~.

Human and mice T~regs~ show similar patterns of heterogeneity {#S8}
-------------------------------------------------------------

Lastly, we investigated whether the conclusions reached about mouse splenic T~regs~ would also apply in human cells. Blood T~regs~ and T~convs~ were sorted (CD4^+^CD25^high^CD127^lo^ and CD4^+^CD25^−^CD127^hi^ respectively; [Fig. 7a](#F7){ref-type="fig"}) from two healthy donors as previously described ^[@R65]^, and their transcriptomes were examined by scRNAseq ([Supplementary Fig. 7a-d](#SD1){ref-type="supplementary-material"}). Aspects of the heterogeneity and inter-relationships between T~reg~ and T~conv~ cells, and of the genes underlying them, proved strikingly similar to the mouse in several important respects.

First, the relative disposition of human CD4^+^ T cells from a tSNE representation ([Fig. 7b,c](#F7){ref-type="fig"}) was similar to the mouse populations. Most T~regs~ and T~convs~ clustered apart, but again furtive T~regs~ trespassed into the T~conv~ zone of the plot ([Fig. 7b](#F7){ref-type="fig"}), actually in even higher proportions (55%) than for mouse splenocytes (26%). These furtive T~regs~ again expressed *FOXP3* ([Fig. 7c](#F7){ref-type="fig"}), albeit at lower levels than did other T~regs~ ([Fig. 7d](#F7){ref-type="fig"}), and T~reg~ signature transcripts were shifted in furtive T~regs~ compared with other T~regs~ ([Fig. 7e](#F7){ref-type="fig"}). Particularly striking was the expression of the two T~reg~ regulators, *BACH2* and *SATB1*, mostly expressed in furtive T~regs~ ([Fig. 7f](#F7){ref-type="fig"}). This over representation of *BACH2* and *SATB1* was also observed in mouse cells, albeit less strikingly. Another region of the tSNE spread exhibited tight co-mingling of T~regs~ and T~convs~ (area C on [Fig. 7b](#F7){ref-type="fig"}), reminiscent of area A-C in the mouse. T~reg~ and T~conv~ cells in these areas still maintained their core transcriptional identity (*FOXP3, IL2RA, HELIOS, CTLA4* for T~reg~, and *THEMIS, ID2, IL7R* for T~conv~) but shared common transcriptional characteristics, uniquely expressing *GZMA, GZMK, GNLY, CCR2* ([Figs. 7g](#F7){ref-type="fig"}, [Supplementary Fig. 7e](#SD1){ref-type="supplementary-material"}).

Secondly, orthologs of the genes that clustered mouse T~regs~ ([Fig. 4c](#F4){ref-type="fig"}) separated human T~regs~, and we could project human T~regs~ to the mouse T~reg~ clusters ([Fig. 7h,i](#F7){ref-type="fig"}). The proportions of human blood T~regs~ in each cluster differed from the mouse splenic T~regs~, with a higher presentation of the activated clusters. *CCR7, SELL, SATB1 and BACH2* again characterized cells belonging to the resting T~reg~ clusters (4, 5, and 6), while *IKZF2* was high in cluster 3, and *S100A4, S100A6 and ITGB1* were frequent in activated clusters 1 and 2. Integrating these data with the existing observations on human T~reg~ heterogeneity, we analyzed the expression of published signature sets ^[@R12],[@R66]^ in our single cells (similar to [Fig. 4b](#F4){ref-type="fig"}). The sets distinguishing activated/memory and resting/naive T~regs~ were differently expressed in clusters 1--2 and 4--6, highlighting the conservation of activation signals between human and mouse T~regs~. In a striking departure from mouse splenic T~regs~, however, very few human blood T~regs~ expressed the set of transcripts dependent on TCR signaling (*NR4A1, EGR1,* or *EGR2)*. This difference is not due to the tissue of origin (mouse blood T~regs~ have the same Nr4a1-GFP profile as splenic T~regs~ - [Supplementary Fig. 7f](#SD1){ref-type="supplementary-material"}), but could be due to different environmental influences on T~reg~ activation in humans and mice. With this exception, however, T~reg~ heterogeneity appears to follow very similar lines in mouse and human immune systems.

DISCUSSION {#S9}
==========

These results bring an unprecedented perspective on T~reg~ diversity, and on what exactly defines a T~reg~ cell, with two overarching considerations. First, T~regs~ are generally distinguishable from T~convs~ within the CD4^+^ T cell space, but the two populations are multiply imbricated, with an important and previously unrecognized degree of overlap, whether among naïve cells or their more differentiated progeny. Second, signals from the TCR play unanticipated roles in shaping the different facets that activated T~regs~ can adopt. This study provides a unifying framework for diverse observations made on T~regs~ in the context of immune homeostasis.

Although scRNAseq lacks the sensitivity to measure the whole transcriptome of a single cell, we leveraged the power of performing scRNAseq on thousands of single cells using droplet microfluidics and applied statistical methods to take into account the technical dropout probability ^[@R53],[@R61],[@R62]^. Thus, conclusions are not drawn from a single cell but from several single cells with closely related programs, residing in the same area of the multidimensional space. With small aggregates of single cells, both technical noise and gene expression stochasticity are mitigated. This approach identifies different cell clusters and estimates the proportion of T~regs~ employing different suppression strategies.

T~reg~ and T~conv~ cells have diametrically opposite functions, and this would suggest sharp boundaries to their transcriptional programs, a notion consistent with the hundreds of transcripts previously found to be differently expressed by population transcriptomics ^[@R17],[@R52]^. However, revisiting this notion at the single-cell level showed that many of these transcripts were not ubiquitously expressed in T~regs~. In fact, only a small core set of transcripts was uniformly expressed throughout all T~regs~, and consistently missing or under-represented in T~convs~, and as such may truly define T~reg~ identity. Some of these transcripts are involved in essential T~reg~ pathways like *Il2ra,* which anchors the IL-2 paracrine loop (made by T~convs~ and used in T~regs~ ^[@R67]^); others encode determining transcription factors (*Foxp3* and *Ikzf2*), or several members of the TNF receptor family (*Tnfrsf4 Tnfrsf18)* ^[@R68]^. But these core T~reg~ transcripts also include some whose function remains conjectural (*Gpr83*) ^[@R69]^, or have yet to be explored (*Izumo1r*, *Capg* or *Wdr92)*. Conversely, T~regs~ consistently lacked the expression of *Igfbp4* and *Dapl1*.

Beyond the core transcripts, T~regs~ and T~convs~ appeared much more imbricated than the comfortable dichotomy of GFP profiles in *Foxp3-gfp* mice would suggest. The overall transcriptomes of furtive T~regs~ were very similar to those of the main T~conv~ population, while still maintaining their core identity (*Foxp3* expression as RNA and protein). They formed a significant portion of T~regs~ (\>20%) in both mouse spleen and human blood. They seemed to be "weaker" T~regs~ as they expressed less Foxp3 and T~reg~ signature genes, and strongly expressed *Satb1* and *Bach2*, two repressors of effector functions ^[@R59],[@R70]^. They likely correspond to the poorly suppressive resting T~regs~ previously described ^[@R12]^. Because of their proportions and CD44^lo^CD62L^hi^ naïve phenotype, it is unlikely that furtive T~regs~ represent activated T~convs~ that transiently express FoxP3 upon activation ^[@R18],[@R19]^, or, at the opposite end of the spectrum, T~regs~ in the process of losing FoxP3 and become activated effector T cells ^[@R71]^. One limitation to these speculations is that there is no rigorous way to infer precursor-product relationships from these data.

Also blurring the demarcation was the observation that some T~reg~ and T~conv~ cells converged to similar transcriptome locations. These were activated cells (by CD44/CD62L criteria) and they expressed specific genesets overriding the core T~reg~/T~conv~ transcriptional difference. This confluence is reminiscent of the earlier reports that TFs characteristic of terminally differentiated T~conv~ states have also a critical role in T~reg~ suppression (*Tbx21, Rorc, Bcl6*) ^[@R7],[@R10],[@R72]--[@R75]^. In one of those convergences, T~regs~ and T~convs~ expressed transcripts known to characterize follicular T cells (in Tfh or Tfr) ^[@R11]^. It is possible that these T~regs~ and T~convs~ converge transcriptionally as a consequence of residing in the same anatomical areas of the spleen, where they receive the same environmental cues ^[@R11],[@R69]^.

These results are therefore consistent with a model defining T~reg~ identity as modular ^[@R17]^. All T~regs~ express a very small core of T~reg~-specific transcripts, onto which additional programs are added, as a function of differentiation and/or location. More generally, our unbiased analysis of T~reg~ heterogeneity revealed that T~regs~ form a continuum gravitating around three major poles. One axis of variation encompasses the previously known resting/activated difference, reflected by CD62L or CCR7 ^[@R12]--[@R15]^. Two transcription factors, *Bach2* and *Satb1*, which modulate T~reg~ differentiation ^[@R47],[@R51],[@R70]^, were comparatively over-expressed in resting T~regs~, and may help maintain this state; interestingly, they seemed to be reciprocally expressed in resting clusters 5 and 6, potentially suggesting redundant functions. However, most of the phenotypic divergence was revealed within the activated T~reg~ compartment, with two orthogonal states of activation associated with differences in TCR signaling strength and suppressor molecule expression.

This single-cell data provided the opportunity to correlate TCR sequence and signaling intensity with the transcriptional output of each T~reg~. We expected that the activated T~reg~ phenotype would be driven by the intensity of TCR signaling. Surprisingly, TCR signal intensity, as indicated by expression of Nr4a1, and confirmed across windows of activity of the *Nr4a1-gfp* reporter, did not correlate with the naïve/activated T~reg~ ratio (reflected by the frequency of cluster 5 and 6 T~regs~, or of *Satb1* and *Bach2* expression). This observation is consistent with the even distribution of CCR7+ T~regs~ across *Nr4a1-gfp* that was previously reported ^[@R14]^, but appears at odds with studies showing that activated T~regs~ electively disappear upon TCR ablation ^[@R27],[@R28]^, a discrepancy which may merely reflect the difference between complete ablation and quantitative variation in transmitted signals. The puzzling disconnect between TCR-derived signals and activated status may also reflect different time-scales: *Nr4a1* is an early-response gene, and the reporter likely responds to short-term stimuli, while the aT~reg~ phenotype may integrate cues over a longer timeframe.

On the other hand, TCR signaling intensity seemed to have a strong influence shaping the different forms of activated T~reg~ differentiation, and hence T~reg~ effector functions. T~regs~ in cluster 3, with the signs of strongest TCR signals, preferentially expressed *Cd24a, Tgfb1*. Perhaps paradoxically, the cluster with the most strongly activated phenotype (cluster 1), which most actively expressed migratory molecules (*Itgb1, Itae, Ccr2*), had the lowest expression of the TCR-response (*Nr4a1, Egr1, Egr2*) cluster. It is possible that those T~regs~ are circulating to (or from) tissues where they encounter cognate antigen. Alternatively, it is known that TCR engagement triggers several signaling cascades ^[@R76]^ and that *Nr4a1* induction is not equally dependent on all (e.g. independent of NF-AT) ^[@R77]^. Thus, low *Nr4a1, Egr1, Egr2* induction may reflect a particular balance of TCR signaling paths, in cluster 1 and 2 T~regs~. In addition, we cannot rule out that the different T~reg~ clusters embody different time periods of activated T~reg~ differentiation, and that TCR signals are dampened by negative feedback in T~regs~ of clusters 1 and 2.

In keeping with the notion that the TCR is a critical component shaping T~reg~ fate, T~regs~ that share the same TCR were more transcriptionally similar than the norm. These similarities did not apply to all clonotypes, in keeping with the observation that T~regs~ in TCR transgenic mice can occupy different organismal and phenotypic niches (^[@R24],[@R78]^ and our unpublished data). The similar quality and intensity of TCR engagement by MHC-peptide ligands may induce similar fine programs in T~regs~ that share the same clonotype. Secondly, the shared antigenic specificity may drive these T~regs~ to the same anatomical location, where they integrate the same environmental cues (MHC-peptide, cytokines, metabolic constraints, etc). Third, this phenomenon could reflect influences received early during T~reg~ differentiation or peripheral activation, which imprint specific programs that persist after emigration to peripheral organs.

In comparing human and mouse T~regs~ at the single-cell level, we observed many similarities. In both species, T~reg~ and T~conv~ cells were distinguishable by the ubiquitous expression of a small core set of transcripts (*FOXP3, IKZF2, TNFRSF1B, IL2RA, IL2RB*). Furtive T~regs~ were found in both species, more frequently in humans, likely explaining why CD45RA^−^ FOXP3^lo^ T~regs~ in humans have very low suppressive activity ^[@R12]^. As in mice, some activated human T~regs~ and T~convs~ co-expressed similar transcriptional programs that overrode the canonical T~reg~:T~conv~ difference. Activated T~regs~ adopted diverse phenotypes in both species, albeit with the striking difference that the population with evidence of high TCR signals was essentially missing in human blood. This might not be a difference between species but between locations, as T~regs~ circulating in the blood may be devoid of MHC/TCR contacts, long enough that the early-response program tunes down.

In conclusion, this study provides a general model for lymphoid T~reg~ identity and heterogeneity that is largely conserved between humans and mice. It also sheds light on a new and unexpected mechanism for the TCR in setting T~reg~ fates. ScRNAseq analysis of complex T cell population provides unique opportunities to identify TCR sequences and other mechanisms modulating T cell fate in health and disease, and manipulating these states ultimately opens avenues to restore homeostasis.

METHODS {#S10}
=======

Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.

Online Methods {#S11}
==============

Mice {#S12}
----

C57BL/6J mice were obtained from The Jackson Laboratory. Foxp3-IRES-GFP/B6 ^[@R79]^ mice were maintained in our colony. All experimentation was performed following animal protocol guidelines of Harvard Medical School (reviewed and approved HMS IACUC protocol 02954). Foxp3-IRES-Thy1.1 ^[@R80]^ mice were crossed with the Nur77-GFP reporter mice ^[@R81]^.

Human blood {#S13}
-----------

Blood was from 2 healthy 32-year-old donors, one male and one female (protocol IRB15--0504).

Flow cytometry {#S14}
--------------

Spleen and blood. Blood was collected by cardiac puncture from euthanized mice and coagulation was prevented by adding heparin (20--50 U/mL blood) (Heparin Sodium Salt, Sigma-Aldrich H3393). A single cell suspension was obtained from murine splenocytes after physical dissociation with a 40 μm mesh (Facon). Red blood cell lysis was performed using 500 uL of ACK (Lonza) for 2 min on ice. Antibody staining was done in ice-cold buffer (DMEM without phenol red-2% FBS) for 5 min at a dilution of 1/100 using with antibodies against CD4 (GK1.5; BioLegend), CD25 (PC61; BioLegend), TCRβ (H57--597; BioLegend), CXCR3 (clone SA011F11, Biolegend), CD62L (MEL-14; BioLegend). Tregs were isolated as CD4+ TCRβ+ Foxp3-GFP+, CD4+ TCRβ+ Foxp3-Thy1.1+ (for the Nur77 experiments). Tconvs were isolated as CD4+ TCRβ+ Foxp3-GFP-.

The protocol of Sefik et al. ^[@R82]^ was used to isolate CD4+TCRβ+FoxP3GFP+ Tregs from the colonic lamina propria. Colonic tissue was dissociated using the following steps. Epithelial cells were removed by treating the tissue with RPMI containing 1 mM DTT, 20 mM EDTA and 2% FBS at 37°C for 15 min, then mincing and dissociating in a collagenase solution (1.5mg/ml collagenase II (Gibco), 0.5mg/ml dispase and 1%FBS in RPMI) with constantly stirring at 37°C for 45 min. Single cell suspensions were then filtered and washed with 4% RPMI solution. CD45+ cells were enriched before sorting using microbeads (Miltenyi Biotec).

Human Tregs and Tconvs were isolated from peripheral blood mononuclear cells (PBMC) as described by Ferraro et al. ^[@R83]^. An equal volume of room-temperature PBS/2mM EDTA was mixed to 15 mL of blood and carefully layered over 14 mL Ficoll-hypaque solution (GE Healthcare). After centrifugation for 30min at 900g (with no break) and room temperature, the mononuclear cell layer was washed 3 times with excess HBSS (Gibco) (10min at 400g) and resuspended in 2mL of HBSS. An FBS gradient was then performed to remove platelets and debris by layering the 2 mL cell suspension over 8mL FBS and centrifuging for 10min at 300g at room temperature. The pellet was resuspended in FACS buffer (phenol red-free DMEM, 2% FBS, 0.1% azide, 10mM Hepes PH 7.9) for antibody-staining in ice for 10min with: anti-CD4 (clone RPA-T4; Biolegend), anti-CD25 (clone BC96; Biolegend), anti-CD127 (clone A019D5; Biolegend), FcBlock (home-made). Treg and Tconvs were sorted as DAPI- CD4+ CD25+ CD127low and DAPI-CD4+ CD25- CD127high, respectively.

Single-cell RNAseq (InDrop) {#S15}
---------------------------

### Library construction {#S16}

scRNAseq was done following the InDrop protocol described in length by Zilionis et al. ^[@R84]^. This technique sequences polyA mRNAs from thousands of single cells in a timely (\< 30 min) and highly efficient manner (\>70--80% of the input cells can be sequenced). Unique Molecular Identifiers are used in order to minimize the noise introduced during amplification. Only 3' ends are sequenced, keeping strand information.

40--80,000 Tregs or Tconvs were first sorted by flow cytometry in complete medium (RPMI 10% FBS). Just before encapsulation, cells were spun for 5 min at 4°C 500g and resuspended in PBS-15% OptiPrep Density Gradient Medium (OptiPrep; Sigma-Aldrich) at a concentration of 80,000 cells/mL. This density gradient prevents sedimentation during encapsulation and allows a uniform flow of cell to enter the microfluidic device. Encapsulation is done by flowing 4 different inputs in the device: cells, reverse transcriptase (RT) buffer, primer hydrogels, and oil (water in oil droplets). Primer hydrogels contain reverse transcriptase (RT) primers with a unique single cell barcode. From 5' to 3', the primer contains a T7 promoter for amplification (in vitro transcription), the PE1 sequencing primer, a unique single cell barcode (16--19bp) (147,456 possible barcodes), a UMI (6bp) and a polyT sequence.

Around 5,000 single cells were then encapsulated in droplets of 3--4 nL containing a primer hydrogel bead and the reverse transcriptase (RT) buffer (SuperScriptIII, Invitrogen). Encapsulation was performed under 30 min in order to maintain cell viability and the emulsion was collected in a 500uL tube.

RT is performed immediately after encapsulation. Firstly, the primers were released from the gels by exposing the emulsion to UV for 7 min. RT was done at 50°C for 2h followed by enzyme inactivation for 15 min at 70°C. Emulsions were then split in small aliquots to have no more than 3'000 cells per tube, broken down by adding adding 20% 1H,1H,2H,2H-perfluorooctanol (PFO) in HFE-7500 oil (3M Novec 7500 Engineered Fluid, Novec) and kept at −80°C.

Samples were thawed on ice and spun at 4°C for 5 minutes at 19,000g to pellet cell debris. Excess primers and hydrogels beads were removed by filtration through a nucleic acid purification column and enzyme digestion (ExoI, HinfI). After purification of the DNA/RNA duplex with 1.2X AMPure beads (Beckman), second-strand cDNA synthesis was performed (NEB) for 2.5 h at 16°C. The library was then amplified using T7 *in vitro* transcription for 15h at 37°C (HiScribe T7 High Yield RNA Synthesis Kit, NEB). After purification, half of the amplified RNA was used for further processing. First, the aRNA was fragmented for 3 min at 70°C (magnesium RNA fragmentation kit, Ambion) and purified using AMPure Beads (1.2X). Then reverse transcription with random hexamers was done for 1h at 42°C (PrimeScript Reverse Transcriptase, Takara Clontec). A final PCR was done to amplify the library and add the P5-P7 and Illumina index primers (Kapa 2× HiFi HotStart PCR mix, Kapa Biosystems). The number of cycles was chosen by first running a qPCR on 1/20th of the RT reaction. The optimum was between 11 and 14 cycles.

Library size was analyzed with a Tapestation (High Sensitivity D1000 ScreenTape, Agilent technologies), quantified by qPCR and sequenced using NextSeq 500 and custom primers (read 1: 40bp, index: 7bp, read 2: 51 bp).

### Data processing and normalization (InDrop). {#S17}

Indrop sequencing data were processed as described by Zilionis et al. ^[@R84]^. Read 1 contains transcript information. Read 2 contains the unique molecular identifier (UMI) (6bp), single-cell barcode (16--19bp) and a conserved sequenced named W1. Fastq reads were first filtered for quality (\>80% with Sanger Q\>20) and on the expected structure of the reads: paired reads were kept only if read 2 contained the W1 and polyT sequence and if read 1 did not contain them. Single cell demultiplexing was performed against the possible barcode space and only reads mapping unambiguously and with less than 2 mismatches were kept. For each single cell library, the reads were then mapped against the mouse mm10 transcriptome (complemented with the sequence of the *Foxp3-cd90.1*- or *Foxp3-gfp* transgenes) using tophat2 v2.0.10 (\--library-type fr-firststrand) ^[@R85]^. Reads mapping to multiple regions or having a low alignment score (MAPQ \<10) were filtered out (flag 256). Duplicated reads were filtered as follows using UMIs and custom scripts [(see Zemmour_Code/CorrectAndCountUMIsEditDist):]{.ul} for each set of reads mapping to one gene, we kept all reads having UMIs with a pairwise string distance \>=2 (Levenshtein distance for taking into account indels and substitution). A final gene-table with genes in rows and cells in columns was then saved. [A CellDataSet object from the Monocle package was used to store the data (see Zemmour_Code/Zemmour_Code.Rmd: \*\*Make a CellDataSet object (from Monocle) \*\*).]{.ul}

A first quality control was performed after demultiplexing by calculating the proportion of total reads that mapped to the most abundant single cell barcodes [(see Zemmour_Code/Zemmour_Code.Rmd: \*\*QC Plots\*\*).]{.ul} Good libraries had \>70% of reads mapping to a small set of single cell barcodes (500--3000) as expected from successful encapsulation. A second quality control involved the distribution of mapping rates and sequencing coverage. Good libraries were normally distributed with an average 80% mapping rate (5% SD) and more than 90% UMI duplicated reads (indicating sequencing saturation).

Single cells with more than 500 genes were kept for the analysis. Total UMI counts normalization was performed and scaled to the median UMI count [(see Zemmour_Code/Zemmour_Code.Rmd: \*\*Normalization and filtering of genes and cells\*\*).]{.ul}

Single-cell RNAseq (CEL-Seq) {#S18}
----------------------------

scRNAseq using the CEL-Seq protocol was done following the protocol described in length in ^[@R86]^. Briefly, Splenic Treg (CD4+ TCRβ+ FoxP3-GFP+) and Tconv (CD4+ TCRβ+ FoxP3-GFP-) cells were index-sorted with a BD FACSAria II in 96-well hard-shell PCR plates filled with 4.4uL of lysis buffer (HSP963, BioRad) containing 0.125 µl of RNAseOut (40 U per 1 µl stock; 10777--019, Invitrogen), 0.25 µl of reverse-transcription primer (25 ng per 1 µl stock) and 4 µl of RNAse-free water (AM9932; Ambion). Index-sorting allowed to record for each sorted single cell the fluorescence intensity of each flow cytometry marker used. After cell sorting, the plates were quickly covered with an aluminum seal (AlumaSeal96; F96100; Excel Scientific), then were vortexed for 10 s, centrifuged for 1 min at maximum speed (\>2250g at 4 °C), frozen on dry ice and kept at −80 °C for up to 3 weeks. RNA was then denatured for 3 min at 70°C and reverse transcribed using ArrayScript Reverse Transcriptase (AM2048 Ambion) and mRNA Second strand synthesis module (E6111L; NEBNext). Single-cell cDNA libraries containing different barcodes were pooled into one tube and *in vitro* transcription was done using MEGAshortscript T7 transcription kit (AM1354; Ambion) for 14h. RNA was then fragmented, ligated to the 3' Illumina adapter and reverse transcribed. Libraries were amplified by PCR and sequenced on a HiSeq 2500.

Data processing is described in length in ^[@R86]^. It followed similar steps as InDrop, filtering reads for quality, mapping to the mm10 transcriptome and filtering duplicated reads out using Unique Molecular Identifiers.

Single-cell RNAseq (10X Genomics) {#S19}
---------------------------------

7000 splenic CD4+ cells from C57/Bl6 mice were sorted by flow cytometry into a well of a chilled 96-well plate filled with 14 ul PBS-0.06% BSA. Cells were then encapsulated in one lane of the 10X Chromium Instrument and libraries were constructed with the Single Cell 3' Reagent Kit (V2 chemistry) (<https://support.10xgenomics.com/single-cell-gene-expression/library-prep>). Libraries were sequenced on NextSeq 500 platform (26/8/0/98, Read1/i7/i5/Read2). Data was analyzed using the Cell Ranger Pipeline (<https://support.10xgenomics.com/single-cell-gene-expression/software/overview/welcome>).

Algorithm to find contaminant cells {#S20}
-----------------------------------

Contamination cells/doublets were identified in the gene table using the following criteria. Firstly, we compared each single cell transcriptome to the Immgen dataset ([www.immgen.org](http://www.immgen.org/)) and calculated the likelihood for each single cell to be any of the Immgen cell types [(see Zemmour_Code/Zemmour_Code.Rmd: \*\*Immgen cell type prediction \*\*).]{.ul} The Immgen matrix of gene expression was used to provide prior probabilities (probability to express *gene i* in *cell type j* = *p*~*ij*~ ) and we calculated for each single cell *C* the likelihood to be of cell type j (*L*~*cj*~) (multinomial model). Log posterior probabilities were derived by normalizing so that they sum to 1 for each single cell.
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Contaminant cells were flagged when a T cell type was not amid the top 5 most likely cell types. Secondly, we performed a PCA on the dataset using the most variable genes. Contaminant cells were flagged as they clustered in the first PCs. Cells usually matching a combination of these two criteria were removed from the analysis. Thirdly, we analyzed the distribution of UMIs and genes in each single cell. Single cells with more than 6,000 UMIs were also filtered out (possible doublets) [(see Zemmour_Code/Zemmour_Code.Rmd: \*\*Removing Contaminant cells\*\*).]{.ul}

Gene expression comparison between groups of single cells {#S21}
---------------------------------------------------------

Differential gene expression was performed using the DESeq statistical model^[@R87]^ (see Zemmour_Code/Zemmour_Code.Rmd: \*\*Differential gene expression function\*\*). The distribution of counts C~ij~ for each gene i in group j is modeled by a negative binomial of parameter $\mu_{{{}_{i}}_{j}}$ (mean) and dispersion *θ~i~*
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First, the dispersion was estimated using the background model according to ^[@R88]^ in which a linear model is fitted between the $\log 2(\mu_{i})$ and $\log 2(\sigma_{i}^{2})$ for each gene i. For each gene *i*, the dispersion $\theta_{i} = \mu_{i}^{2}/(\max(\mu_{i} + 10^{- 6},s_{\mu_{i}}^{2})) - \mu_{i})$, was estimated, $s_{\mu_{i}}^{2}$being the fitted variance of gene *i*. A generalized linear model was then fit for each gene *i* in each group *j* \[glm(formula = gene \~ groups, data = tmp, family = negative.binomial($\theta_{i}$))\] and we used an analysis of variance (anova) to compare the coefficients in each model and get a p-value. FDR was calculated to correct for multiple testing.

To identify the core Treg transcripts independently of other variables like activation, we compared matched Tregs and Tconvs (see Zemmour_Code/Zemmour_Code.Rmd: \*\*Core Treg genes\*\*). For each single Treg cell (n = 708), we compared its 50 closest Tregs and 50 closest Tconvs (correlation distance) and deemed significant genes with a p value \< 0.05. Core Treg genes scored as significantly different in \> 80% of the comparisons.

tSNE representation and clustering {#S22}
----------------------------------

Data was visualized using the t-Distributed Stochastic Neighbor Embedding (t-SNE) dimensionality reduction algorithm ^[@R89]^ (see Zemmour_Code/Zemmour_Code.Rmd: \*\*t-SNE\*\*). A PCA was first performed on the top 100 most variable genes that were expressed in more than 1% of the cells. The Fano factor (variance/mean) was used as a metric for variability because of its independence to the mean in Poisson distributed data. The number of significant PCs were determined by comparison to PCA over a randomized matrix as described by Klein et al. ^[@R90]^. Two-dimensional tSNE was run using the Rtsne function ^[@R88]^, on the significant PCs, setting the seed for reproducibility and using the following parameters (perplexity = 50, max_iter = 1000).

Clustering was done independently of the tSNE projections based on k-means and the method described by Krijthe et al. ^[@R91]^, using the clusterboot function in R and kmeansCBI ^[@R92]^ on the significant PCs (see Zemmour_Code/Zemmour_Code.Rmd: \*\*Clustering\*\*). Cluster stability was assessed by bootstrapping and analyzed with the Jaccard index (average similarity between the closest clusters during bootstrapping) and silhouette plots (difference between the average distance for each single cell to cells in the same cluster versus cells in the closest cluster). The number of clusters (k) was optimized by running the algorithm with different k and choosing the largest k with the most stable clusters (all clusters with a Jaccard index \> 0.6). Cluster coherence was also assessed by visualizing them on the tSNE plots.

Circular A Posteriori Projection plots {#S23}
--------------------------------------

In order to compare the different single cell dataset replicates, we calculated the likelihood for each single cell to belong to the spleen Treg clusters defined in [Fig. 4](#F4){ref-type="fig"} [(see Zemmour_Code/Zemmour_Code.Rmd: \*\*Circular A Posteriori Projection plots\*\*).]{.ul} The average expression within each cluster of [Fig. 4](#F4){ref-type="fig"} was used as prior probabilities and we used a multinomial mixture model as described by Jaitin et al. ^[@R93]^ (and above for the contamination algorithm) to calculate the log posterior probabilities for each single cell to belong to any of the spleen clusters. For the human data, we used the ortholog genes ([www.informatics.jax.org/downloads/reports/index.html\#homology](http://www.informatics.jax.org/downloads/reports/index.html#homology))

These probabilities were visualized as described by Jaitin et al. ^[@R93]^ using Circular A Posteriori (CAP) plots. The probabilities were projected on a 2-dimensional sphere using radial positions reflecting the relationship between clusters (a = (pi/2, pi/4, 3\*pi/4, −3\*pi/4, -pi/4, -pi/2) for clusters 1 to 6). For each single cell c and cluster k, the x and y coordinates were then calculated as $$x_{c} = \sum\limits_{k}Pck*\cos(a_{k})$$ $$y_{c} = \sum\limits_{k}Pck*\sin(a_{k})$$

Treg signatures and single cell score {#S24}
-------------------------------------

Genes signatures were curated from published datasets (references in [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}) and computed by comparison between two conditions (e.g. WT vs KO). Data were downloaded from GEO. Only datasets containing replicates were used. To reduce noise, genes with a coefficient of variation between biological replicates \> 0.6 in either comparison groups were selected. Up- and down-regulated transcripts were defined as having a fold change in gene expression \> 1.5 or \< 2/3 and a t.test p-value \< 0.05 . Others signatures were obtained from Godec et al. ^[@R94]^.

A signature score for each single cell was computed by summing the counts for the up-regulated genes and subtracting the counts for the down-regulated genes. Z-score were plotted in the heatmap ([Fig. 4b](#F4){ref-type="fig"}) [(see Zemmour_Code/Zemmour_Code.Rmd: \*\*Treg signatures and single cell score\*\*).]{.ul}

Correcting technical dropouts in scRNAseq to estimate frequency of expression {#S25}
-----------------------------------------------------------------------------

Frequency of expression is underestimated in single cell RNAseq studies because of the low sensitivity of the technique. However, several statistical methods have been developed to estimate technical dropouts ^[@R86],[@R95],[@R96]^ [(see Zemmour_Code/Zemmour_Code.Rmd: \*\*Correcting technical dropouts in scRNAseq to estimate frequency of expression\*\*).]{.ul} Genes were first distributed in 25 bins of expression according to the population average. Then, for each single cell *c*, we calculated the fraction of genes that were expressed in each bin (count \>=1) and fit a logistic regression to predict the dropout probability for each gene in the single cell. Goodness of fit was assessed by calculated the area under the ROC curve (AUC). 99% of the cells had an AUC between 0.88 and 0.9. Dropout-corrected gene expression for each single cell *c* and gene *i* (*CorrectedCount*~*i*,c~) was calculated using these dropout probabilities (*dropout*~*i*,c~) as weight and the average expression of the 10 closest genes (by correlation distance) ($\mu_{i}$) as expected counts.
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Frequency of expression was calculated using the dropout-corrected gene expression (*CorrectedCount \> 0*).

Paired single cell TCRαβ sequencing {#S26}
-----------------------------------

Single-cell TCRαβ sequencing was done from 1 batch of splenic Tregs and 2 batches of colonic Tregs isolated from SPF mice. Single-cell TCRαβ sequencing was done on the same material as for the whole-transcriptome library construction, taking a small amount of material after the RNA amplification and before the fragmentation step. The protocol starts by taking an aliquot of the aRNA library before fragmentation as it retained full transcript sequence and performing a reverse transcription using TRAV and TRBV external primers ([Supplementary Table 5](#SD7){ref-type="supplementary-material"}). The sequences of the external and internal primers were obtained from ref ^[@R97]^ for TRBV and ref ^[@R98]^ for TRAV. The Illumina PE1 sequencing primer was added to the 5' end of the internal primers ([Supplementary Table 5](#SD7){ref-type="supplementary-material"}). TCRα and TCRβ RT reactions were performed separately following the protocol for SuperScriptIII (Invitrogen): 1uL of the aRNA was mixed with 1uL of RT primers (external TRAV or TRBV primers) (10uM), 1uL of dNTP and 10uL of RNAse-free water and incubated at 65°C for 5 min before adding 4uL of SuperScriptIII (Invitrogen) buffer 5X, 1uL of DTT, 1 uL of RNAseOut (Invitrogen) and incubating for 50 min at 50°C, then for 70°C for 15 min. cDNA library was purified and size selected using 0.5X AMPure SPRI bead. The first PCR uses internal primers and adds PE1 sequencing primers. A qPCR was performed before to optimize the number of cycles needed for PCR1 using 1/10 of the previous purified cDNA (1uL), 5uL water, 10uL KAPA ReadyMix 2X (Kapa Biosystems), 2uL SYBRgreen (Invitrogen), 1uL of primers (RTP_TRAV or RTP_TRBV) (10µM), 1uL of P7_Rd2_idxN (10uM). Cycle parameters were: 95°C 3min; 40 cycles of: 98 °C 20s -\> 60°C 30s -\> 72°C 1min \--\> fluorescence read. The number of optimized cycles corresponded to the middle of the exponential phase (to which log2(10) = 3.3 cycles are subtracted, since the PCR uses 9 times more cDNA than the qPCR). PCR1 was then performed as follows: cDNA (10uL), 11uL water, 25uL KAPA ReadyMix 2X (Kapa Biosystems), 2uL of primers (RTP_TRAV or RTP_TRBV) (10µM), 2uL of P7_Rd2_primer_idxN_R (10uM). Cycle parameters were: 95°C 3min; X cycles of: 98 °C 20s -\> 60°C 30s -\> 72°C 1min. The PCR product was then purified and size selected using 0.5X AMPure SPRI bead. A second PCR incorporates the P5 Illumina sequence and done as follows: purified PCR1 product (5uL), 16uL water, 25uL KAPA ReadyMix 2X (Kapa Biosystems), 2uL of primers P5_Rd1 (10uM), 2uL of P7_Rd2_idxN (10uM). Cycle parameters were: 95°C 3min; X cycles of: 98 °C 20s -\> 60°C 30s -\> 72°C 1min. The number of cycles for PCR2 were optimized using a qPCR as described above (\<10 cycles). PCR3 product was then purified and size selected twice using 0.5X AMPure SPRI beads. Library size was assessed using a High sensitivity D5000 ScreenTape (Agilent). TCRα and TCRβ libraries have an expected size of 1470 and 1230bp, respectively. Library concentration was determined by qPCR. Sequencing was done using paired-end NanoMiseq Read1: 265 bp, index:7 bp, Read2: 51 bp.

Read 1 contains the TCR transcript sequence. Read 2 contains the unique molecular identifier (UMI) (6bp), single-cell barcode (16--19bp) and a conserved sequenced named W1(similarly to the whole transcriptome analysis). As for the transcriptome analysis, Fastq reads were first filtered for quality (\>80% with Sanger Q\>20) and on the expected structure of the reads: paired reads were kept only if read 2 contained the W1 and polyT sequence and if read 1 did not contain them. Single cell demultiplexing was performed against the possible barcode space and only reads mapping unambiguously and with less than 2 mismatches were kept. TCRα and TCRβ alignment (V,D,J alignment and CDR3 identification) was done individually for each single cell against the mouse IMGT database ([www.imgt.org](http://www.imgt.org/)) using the Mixcr 1.8.1 program ^[@R99]^: mixcr.jar align -f \--library local -nw -OminSumScore=0 \--loci \$loci -OjParameters.parameters.floatingRightBound=False -OdParameters.absoluteMinScore=0 \--species mmu \--report \$line.\$loci.aln.log \$line.fq \$line.\$loci.aln.vdjca; mixcr.jar exportAlignmentsPretty \--skip 0 \--limit 10 \$line.\$loci.aln.vdjca \$line.\$loci.aln.pretty.txt; mixcr.jar exportAlignments -f -p full \--no-spaces \$line.\$loci.aln.vdjca \$line.\$loci.aln.txt; mixcr.jar assemble -f \$line.\$loci.aln.vdjca \--report \$line.\$loci.asmbl.log \$line.\$loci.asmbl.clns; mixcr.jar exportClones -f -p full \--no-spaces \$line.\$loci.asmbl.clns \$line.\$loci.asmbl.txt. Only sequences with a score \> 100 were kept for further analysis. TCRα, TCRβ sequences and whole transcriptome data were matched to the same single cell barcode unambiguously with less than 2 mismatches. Only single cell barcodes with both TCRα and TCRβ sequences and for which the transcriptome was available were kept for further analysis. Single cells were grouped in clonotypes when sharing the same TCRα and TCRβ sequences (V,D,J and CDR3 sequence).
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![T~reg~ *and* T~conv~ *cell scRNAseq datasets*\
**a**. Flow cytometric plot of gated CD4^+^TCRβ^+^ T~reg~ and T~conv~ cells from *Foxp3.gfp* mice sorted for scRNAseq library construction. Representative of 5 experiments.\
**b**. Single cell transcriptome coverage, shown as the number of uniquely identified mRNA reads per cell (X-axis) vs the number of expressed genes per single cell, in 3 T~reg~ biological replicate datasets and the T~conv~ dataset. Single cells with less than 500 transcripts sequenced were excluded from further analysis.\
**c**. Scatterplot representing the expression (normalized counts) of *Foxp3* and *Il2ra* in the single T~reg~ (n = 708) and T~conv~ cells (n = 1098).](nihms-935631-f0001){#F1}

![*Some* T~regs~ *and* T~conv~ *cells show closely related transcriptome*\
**a**. Two-dimensional tSNE plot of T~reg~ (red dots) and T~conv~ (black) single cell transcriptomes (each dot represents one cell) with different areas (A-E) identified by unsupervised clustering. The proportions of T~regs~ and T~convs~ in each area relative to the total number of T~regs~ and T~convs~ is indicated.\
**b.** Same tSNE plots as in a, but split to show T~reg~ and T~conv~ cells separately (top row) and cells in which *Foxp3* transcript was detected (bottom row; the size of each dot indicates the level of *Foxp3* RNA expression.\
**c.** Foxp3 expression (normalized counts) in "furtive" T~regs~ in area E in comparison to T~regs~ outside area E. Error bar: mean and 95% CI. \* p \< 0.05 (t-test)\
**d.** Furtive T~regs~ show the usual biased transcriptome for T~reg~ signature genes. Volcano plot (foldchange versus p value) comparing the gene expression profiles of furtive T~reg~ versus main T~conv~ (both from area E of the plot). Up- and down-regulated T~reg~ signature genes ^[@R17]^ are highlighted (red and blue respectively). χ2 test p.values\
**e.** T~reg~/T~conv~ expression ratio for furtive T~regs~ in area E (x-axis) vs T~reg~/T~conv~ ratio outside area E (x-axis). Up- and down-regulated T~reg~ signature genes are highlighted (red and blue respectively). Gene list are the genes gated on the plot.\
**f.** Down-tuning of the T~reg~ signature in furtive T~regs~. Volcano plot comparing the gene expression profiles of furtive versus other T~regs~ (in and outside area E, respectively). Up- and down-regulated T~reg~ signature genes are highlighted (red and blue respectively). χ2 test p values.\
**g.** T~regs~ and T~convs~ in area A differentially express the same set of genes compared to their respective main populations. Ratio of gene expression in T~regs~ in A vs D (x-axis) against the ratio of expression in T~convs~ in A vs E (y-axis).\
**h.** Same tSNE plot as in a, highlighting cells expressing Tfr signature transcripts ^[@R11]^.\
**i.** T~regs~ and T~convs~ in area B differentially express the same set of genes compared to their respective main populations. Ratio of gene expression in T~regs~ in B vs D (x-axis) against the ratio of expression in T~convs~ in B vs E (y-axis).\
**j.** Same tSNE plot as in a, highlighting cells expressing the most up regulated genes after TCR activation ^[@R49]^\
**k.** Presence/absence (black/white) heatmap showing the core T~reg~ transcripts expressed in all T~regs~ regardless of their area (each vertical line represents one cell).](nihms-935631-f0002){#F2}

![T~reg~ *signature expression in single* T~reg~ *and* T~conv~ *cells*\
**a.** Mean expression in collapsed T~reg~ and T~conv~ single-cell datasets (normalized counts). Canonical up- and down-regulated T~reg~ signature genes ^[@R17]^ are highlighted (red and blue respectively).\
**b.** Gene-gene correlation heatmap for the canonical T~reg~ signature genes, calculated across all T~reg~ and T~conv~ single-cell datasets.\
**c.** Gene-gene as in b, but calculated in T~reg~ single-cell datasets only.](nihms-935631-f0003){#F3}

![*Resting and activated* T~reg~ *states identified by scRNAseq*\
**a.** Biclustering heatmap of the expression of the most characteristic genes for each T~reg~ cluster (down-sampled to equilibrate cluster size; each vertical line represents one cell)\
**b.** Biclustering heatmap of expression signatures in T~reg~ cells belonging to different clusters (cell and clusters aligned with a).\
**c.** Circular a posteriori projection plot (CAP) ^[@R40]^. Each single cell is projected on a circular plan according to its likelihood to belong to any of the 6 clusters defined in a (n = 708). The proportion of cells in each cluster is indicated.\
**d.** Same tSNE plots as in [Fig. 2a](#F2){ref-type="fig"}, highlighting the location of individual T~reg~ cells from each of the T~reg~ clusters.\
**e.** *Cxcr3*, *Cd62l* and *Nr4a1* expression in single T~reg~ cells determined by flow cytometry (top row, representative of 3 experiments) or by scRNAseq (corrected counts, bottom row). Top right: Nr4a1-GFP expression in CXCR3^−^ and CXCR3^+^ T~regs~ (as gated),\* p \< 0.05 (t-test).\
**f.** Proportion of cells in each T~reg~ cluster (defined in a) that express different effector transcripts. Proportion calculated after correction for dropout events (see Methods). \*\*\* p \< 10^−4^ (ANOVA).](nihms-935631-f0004){#F4}

![T~reg~ *states associated with different TCR signaling strength*\
**a.** Foxp3-Thy1.1 versus Nr4a1-GFP expression in gated CD4^+^TCRβ^+^ T cells by flow cytometry showing the gating strategy used to sort Nr4a1-GFP-high, -medium and -low T~reg~ cells before microfluidic encapsulation for scRNAseq library construction. Right: *Nr4a1* expression in the corresponding Nr4a1-high, -medium and --low scRNAseq datasets (n = 1266, 1265 and 1567 respectively) (red bar: average and 95% CI in expressing cells).\
**b.** Two-dimensional tSNE plot of Nr4a1-high, -medium and --low T~regs~. The heat colors represent densities of cells.\
**c.** Left: bar plot representing the proportion of T~regs~ belonging to the resting clusters 5 and 6 (defined in [Fig. 4](#F4){ref-type="fig"}) in Nr4a1-high, -medium and --low T~regs~. Left: in the scRNAseq datasets (cluster 5 and 6, in green and turquoise respectively). Right: expression of CD62L (flow cytometry, representative of n = 4 experiments) among the three Nr4a1 cell sets.\
**d.** Bar plot representing the proportion of T~reg~ cell belonging activated T~reg~ clusters (defined in [Fig. 4a](#F4){ref-type="fig"})) in Nr4a1-high, -medium and --low T~regs~.\
**e.** CXCR3 expression in Nr4a1-high, -medium and --low T~regs~ by flow cytometry. Left: Representative CXCR3 histograms; Right: Proportion of CXCR3^+^ cells in Nr4a1-high, -medium and --low T~regs~ (as gated in the histograms, dashed line in the histograms). Gated on CD4^+^TCRβ^+^FoxP3^+^ cells (n = 4).](nihms-935631-f0005){#F5}

![T^regs^ *that express the same TCRαβ sequence have related transcriptional programs*\
**a.** Two-dimensional tSNE plot of T~regs~ from the colon lamina propria, in 7 panels to highlight in red single T~reg~ cells with the same rearranged TCRαβ sequences. V/J alleles and CDR3 sequences indicated above each panel. Data from 2 different experiments (top 4 and bottom 3 panels).\
**b.** Cell-cell correlation between colonic T~reg~ cells that express the same rearranged TCRαβ, or unrelated TCRs , \*\*\* p \< 10^−4^ (t test p value).](nihms-935631-f0006){#F6}

![*Similitudes in human and mouse* T~reg~ *heterogeneity*\
**a.** Flow cytometric plot of gated CD4^+^ T~reg~ and T~conv~ cells in human blood defined by CD127 and CD25 expression, showing the sorting gates used before microfluidic encapsulation and scRNAseq library construction. Representative of cells isolated from 2 different donors.\
**b.** Two-dimensional tSNE plot from transcriptomes of single human T~reg~ (red dots, n = 741) and T~conv~ (black, n = 1008) single cells, with different areas (A-C) identified by unsupervised clustering. Each dot is an individual cell. The proportions of T~regs~ and T~convs~ in each area relative to the total number of T~regs~ and T~convs~ is indicated.\
**c.** Same tSNE plots of human T~reg~ and T~conv~ as in b, but split to show T~reg~ and T~conv~ cells separately (top row) and cells in which *FOXP3* transcript was detected (bottom row; the size of each dot indicates the level of *FOXP3* RNA expression.\
**d.** *FOXP3* expression (normalized counts) in T~regs~ in area A (furtive T~regs~) in comparison to T~regs~ outside area A (bar: mean and 95% CI. \*: t.text p value \< 0.05.\
**e.** Volcano plot comparing the gene expression profiles of human furtive T~regs~ (in area A) vs all other T~regs~ (outside area A). Human up- and down-regulated T~reg~ signature genes are highlighted (red and blue respectively). χ2 test p-values\
**f.** tSNE plots as in b, highlighting *BACH2-* and *SATB1*-expressing T~reg~ cells (red). Dot size: level of expression in each cell cell.\
**g.** Fold change/fold change plot comparing the gene expression profiles of T~regs~ in C and A areas (x axis) with the gene expression profiles of T~convs~ in C and A areas (y axis). Highlighted genes are genes specifically expressed by both T~regs~ and T~convs~ in area C.\
**h.** Biclustering expression heatmap of human blood T~regs~, grouped into the equivalent of the 6 mouse clusters (defined in [Fig. 4](#F4){ref-type="fig"}) using a likelihood model (see Methods), based on expression of human orthologs of the mouse genes (Top). Biclustering heatmap of published activated/resting signatures ^[@R12],[@R66]^ (Bottom). Each vertical line represents one cell. The proportions of cells in each cluster is indicated.\
**i.** Circular projection plot of the likelihood for each single human T~reg~ cell to belong to any of the 6 clusters defined by homology to the mouse T~reg~ clusters defined in [Fig. 4](#F4){ref-type="fig"}.](nihms-935631-f0007){#F7}
